AU5068999A - Lipid emulsion and solid lipid nanoparticle as a gene or drug carrier - Google Patents
Lipid emulsion and solid lipid nanoparticle as a gene or drug carrierInfo
- Publication number
- AU5068999A AU5068999A AU50689/99A AU5068999A AU5068999A AU 5068999 A AU5068999 A AU 5068999A AU 50689/99 A AU50689/99 A AU 50689/99A AU 5068999 A AU5068999 A AU 5068999A AU 5068999 A AU5068999 A AU 5068999A
- Authority
- AU
- Australia
- Prior art keywords
- gene
- lipid
- drug carrier
- emulsion
- solid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Dispersion Chemistry (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Optics & Photonics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Transplantation (AREA)
- Biochemistry (AREA)
- Nanotechnology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR19980031249 | 1998-07-31 | ||
| KR9831249 | 1998-07-31 | ||
| PCT/KR1999/000414 WO2000006120A1 (en) | 1998-07-31 | 1999-07-30 | Lipid emulsion and solid lipid nanoparticle as a gene or drug carrier |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU5068999A true AU5068999A (en) | 2000-02-21 |
Family
ID=19546046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU50689/99A Abandoned AU5068999A (en) | 1998-07-31 | 1999-07-30 | Lipid emulsion and solid lipid nanoparticle as a gene or drug carrier |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1100464A1 (en) |
| JP (1) | JP2002521423A (en) |
| KR (1) | KR100374482B1 (en) |
| AU (1) | AU5068999A (en) |
| WO (1) | WO2000006120A1 (en) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ512599A (en) | 1998-12-30 | 2003-10-31 | Dexcel Ltd | Formulation for cyclosporin administration featuring a hydrophilic solvent and a surfactant with a HLB of less than 5 |
| JP2002537102A (en) * | 1999-02-26 | 2002-11-05 | カイロン コーポレイション | Microemulsion with adsorbed polymer and fine particles |
| MXPA01011660A (en) * | 1999-05-20 | 2004-04-05 | Pharmasol Gmbh | Stability, biocompatibility optimized adjuvant (sba) for enhancing humoral and cellular immune response. |
| US7153525B1 (en) | 2000-03-22 | 2006-12-26 | The University Of Kentucky Research Foundation | Microemulsions as precursors to solid nanoparticles |
| EP1355670A2 (en) * | 2000-04-20 | 2003-10-29 | University of British Columbia | Enhanced stabilised plasmid-lipid particle-mediated transfection using endosomal membrane destabilisers |
| US7189705B2 (en) | 2000-04-20 | 2007-03-13 | The University Of British Columbia | Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers |
| JP2001300287A (en) * | 2000-04-20 | 2001-10-30 | Nof Corp | Perfluorocarbon emulsion formulation |
| KR100618033B1 (en) * | 2004-06-21 | 2006-08-30 | 에이엔에이치 케어연구소(주) | External preparation composition for the treatment of atopic diseases containing doxepine hydrochloride as an active ingredient |
| PL1940439T3 (en) | 2005-08-11 | 2011-04-29 | Univ Saskatchewan | Reducing post-operative adhesion formation with intraperitoneal glutamine |
| US8530436B2 (en) | 2007-01-29 | 2013-09-10 | Transderm, Inc. | Methods and compositions for transdermal delivery of nucleotides |
| CA2578647A1 (en) * | 2007-02-15 | 2008-08-15 | University Of Saskatchewan | Reducing post-operative adhesion formation with intraperitoneal glutamine |
| WO2009149418A2 (en) | 2008-06-06 | 2009-12-10 | Asuragen, Inc. | Novel compositions for the in vivo delivery of rnai agents |
| GB0901857D0 (en) * | 2009-02-05 | 2009-03-11 | Nanoco Technologies Ltd | Encapsulated nanoparticles |
| EA013570B1 (en) * | 2009-02-24 | 2010-06-30 | Ооо "Научно-Производственный Комплекс "Наносистема"" | Pharmaceutical composition for treating tuberculosis and diseases mediated by helicobacter pylori based on solid lipid nanoparticles and a method for the treatment of tuberculosis |
| ES2351756B1 (en) * | 2009-07-28 | 2011-10-05 | Universidad Del Pais Vasco | LIPID NANOPARTICLES FOR GENE THERAPY. |
| AU2010328336B2 (en) | 2009-12-07 | 2017-03-02 | Arbutus Biopharma Corporation | Compositions for nucleic acid delivery |
| DE102010013064A1 (en) * | 2010-03-26 | 2011-12-15 | Gabriele Blume | Novel carrier system for the transport of active ingredients into the skin |
| EP2590625B1 (en) * | 2010-07-06 | 2017-09-20 | GlaxoSmithKline Biologicals SA | Cationic oil-in-water emulsions |
| ES2385080B1 (en) * | 2010-12-21 | 2013-05-10 | Universidad Del Pais Vasco-Euskal Herriko Unibertsitatea | LIPID NANOPARTICLES FOR THE TREATMENT OF EYE DISEASES. |
| BR112013031553A2 (en) | 2011-06-08 | 2020-11-10 | Shire Human Genetic Therapies, Inc. | compositions, mrna encoding a gland and its use, use of at least one mrna molecule and a vehicle for transfer and use of an mrna encoding for exogenous protein |
| MX350258B (en) * | 2011-07-06 | 2017-08-31 | Novartis Ag | Cationic oil-in-water emulsions. |
| CN107596518B (en) | 2012-02-29 | 2021-04-23 | 普马特里克斯营业公司 | Inhalable dry powder |
| US9693936B2 (en) | 2012-03-07 | 2017-07-04 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Dispersions in oil of Dead Sea nano sized material preparation and uses therof |
| CN102670484B (en) * | 2012-05-30 | 2013-06-05 | 浙江大学 | Mannose-modified solid lipid nanoparticle plural gel and preparation method thereof |
| BR102012015756A2 (en) * | 2012-06-26 | 2014-12-02 | Univ Fed De Ouro Preto Ufop | PROCEDURE FOR OBTAINING HIGH CONCENTRATIONS OF THE CHEMICAL CONSTITUTE TRANS-PINOCARVILLE ACETATE FOR HYDRODESTILATION OF THE GRAVEOLEN AIR PARTIES AND OBTAINING NANOEMULSIONAL FORMULATIONS. |
| AU2013351934B2 (en) * | 2012-11-30 | 2018-03-29 | Insmed Incorporated | Prostacylin compositions and methods for using the same |
| US20140271923A1 (en) | 2013-03-14 | 2014-09-18 | Christopher Brian Reid | Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions |
| US20140275261A1 (en) | 2013-03-15 | 2014-09-18 | Dr. Reddy's Laboratories, Inc. | Diclofenac parenteral compositions |
| CA2927788C (en) | 2013-10-25 | 2022-09-06 | Insmed Incorporated | Prostacyclin compounds, compositions and methods of use thereof |
| KR101671864B1 (en) * | 2014-08-29 | 2016-11-04 | 세종대학교 산학협력단 | Cationic emulsion containing iodized oil and use of the cationic emulsion for promoting gene delivery of virus vector |
| CN107072964A (en) | 2014-11-05 | 2017-08-18 | 西莱克塔生物科技公司 | Methods and compositions related to the use of low HLB surfactants in the production of synthetic nanoparticles comprising RAPALOG |
| EP3904326A1 (en) | 2014-11-18 | 2021-11-03 | Insmed Incorporated | Methods of manufacturing treprostinil and treprostinil derivative prodrugs |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
| MX2018011705A (en) | 2016-04-01 | 2019-06-10 | Therapeuticsmd Inc | Steroid hormone pharmaceutical composition. |
| BR102017016440A2 (en) * | 2017-07-31 | 2019-03-19 | Universidade Federal Do Rio Grande Do Sul | COMPOSITION FOR CENTRAL NERVOUS SYSTEM GENE THERAPY, OBTAINING AND USE PROCESS |
| KR20220002600A (en) | 2019-04-29 | 2022-01-06 | 인스메드 인코포레이티드 | Dry powder composition of treprostinil prodrug and method of use thereof |
| CN111281982B (en) * | 2020-02-19 | 2023-11-17 | 深圳厚存纳米药业有限公司 | A complex of poloxamer and/or poloxamine combined with lipids |
| EP4117631A1 (en) | 2020-03-11 | 2023-01-18 | Selecta Biosciences, Inc. | Methods and compositions related to synthetic nanocarriers |
| EP4056038A1 (en) * | 2021-03-10 | 2022-09-14 | Basf Se | Microparticles containing active substances |
| CN113350521B (en) * | 2021-04-08 | 2022-11-29 | 上海大学 | LPD nano liposome and preparation method and application thereof |
| CN113877000B (en) * | 2021-10-13 | 2023-01-24 | 科笛生物医药(无锡)有限公司 | Microsphere composition for injection and application thereof |
| CN114657147B (en) * | 2022-01-27 | 2023-12-01 | 安徽智飞龙科马生物制药有限公司 | Protective agent for biological material and application thereof |
| CA3252827A1 (en) * | 2022-03-10 | 2023-09-14 | Nammi Therapeutics, Inc. | Formulated and/or co-formulated lipid nanocarriers compositions containing toll-like receptor ("tlr") agonist prodrugs useful in the treatment of cancer and methods thereof |
| CN115887253B (en) * | 2022-10-20 | 2025-10-24 | 华南理工大学 | A squalane-based nanolipid carrier loaded with ethyl ferulate, and its preparation method and application |
| CN121398801A (en) * | 2023-06-28 | 2026-01-23 | 赛诺菲巴斯德有限公司 | Uses of glycerides in LNP formulations |
| CN120346163A (en) * | 2024-01-22 | 2025-07-22 | 中国科学院过程工程研究所 | Oil-in-water emulsion |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0344314A (en) * | 1989-07-13 | 1991-02-26 | Nippon Petrochem Co Ltd | Hair dyeing assistant for acid dye |
| DE4039063A1 (en) * | 1990-12-07 | 1992-06-11 | Wella Ag | HAIR CURING IN THE FORM OF A MICROEMULSION |
| JPH06508555A (en) * | 1991-06-27 | 1994-09-29 | エモリイ・ユニバーシテイ | Multiphase emulsion and manufacturing method |
| JPH06219940A (en) * | 1993-01-27 | 1994-08-09 | Shiseido Co Ltd | Patch |
| AU4868396A (en) * | 1995-02-22 | 1996-09-11 | Bausch & Lomb Incorporated | Skin care composition |
-
1999
- 1999-07-30 AU AU50689/99A patent/AU5068999A/en not_active Abandoned
- 1999-07-30 WO PCT/KR1999/000414 patent/WO2000006120A1/en not_active Ceased
- 1999-07-30 EP EP99935145A patent/EP1100464A1/en not_active Withdrawn
- 1999-07-30 JP JP2000561977A patent/JP2002521423A/en not_active Withdrawn
-
2002
- 2002-01-30 KR KR10-2002-0005448A patent/KR100374482B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR20020033665A (en) | 2002-05-07 |
| KR100374482B1 (en) | 2003-03-03 |
| EP1100464A1 (en) | 2001-05-23 |
| WO2000006120A1 (en) | 2000-02-10 |
| JP2002521423A (en) | 2002-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU5068999A (en) | Lipid emulsion and solid lipid nanoparticle as a gene or drug carrier | |
| AU5273200A (en) | Emulsion vehicle for poorly soluble drugs | |
| AU4818099A (en) | Phosphodiesterase-v modulator drugs and their uses | |
| AU1603199A (en) | Methods and devices for measuring differential gene expression | |
| AU5020400A (en) | Heteroaryloxypyrimidine insecticides and acaricides | |
| AU6876498A (en) | Intravesical drug delivery system | |
| AU3068599A (en) | Medication infusion set | |
| AU7832498A (en) | System for facilitating drug discovery data and method thereof | |
| AU2387997A (en) | Stabilized medicaments containing cysteinyl derivatives | |
| AU7538398A (en) | Emulsion for well and formation treatment | |
| AU4892897A (en) | Phospholipid drug derivatives | |
| AU9646198A (en) | Isoquinoline derivative and drug | |
| AU3999699A (en) | Targeted liposomal drug delivery system | |
| AU8456198A (en) | Taxol emulsion | |
| AU1409100A (en) | Drugs | |
| AU2543399A (en) | Anticonvulsant drugs and pharmaceutical compositions thereof | |
| AU1502799A (en) | Pharmaceutical composition comprising clioquinol and vitamin B12 | |
| AU3072500A (en) | Rhamnosyl-transferase gene and uses thereof | |
| AU5471600A (en) | Variant tlr4 nucleic acid and uses thereof | |
| AU6977898A (en) | Strategic marketing system | |
| AU6940998A (en) | Phospholipid drug derivatives | |
| AU8382998A (en) | P53 influenced gene expression | |
| AU9344398A (en) | Tetraether lipid derivatives and liposomes and lipid agglomerates containing tetraetherlipid derivatives, and use thereof | |
| AU3357700A (en) | Phenoxypyrimidine insecticides and acaricides | |
| AU6683998A (en) | Aortic cannula |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |